Circulate

Circulate Health is focused on the anti-aging and wellness market by providing Therapeutic Plasma Exchange (TPE) treatments. The company's core offering is built upon proprietary, FDA-cleared apheresis technology, which is supported by two decades of scientific research and clinical trials.

The business operates on a partnership model, expanding its services through a network of independent medical practices and clinics. Currently, TPE by Circulate is available in over 21 clinics across the United States, with a clear strategy for continued growth. This model allows the company to scale its reach by equipping partner clinics to deliver the treatments.

Circulate targets two primary client segments: patients seeking treatments to improve their quality of life and healthy lifespan, and medical clinics or doctor's offices looking to offer these services. The company's revenue is likely generated through the provision of its TPE technology and services to its partner clinics, which in turn serve the end patients. Clinical services are delivered by these independent practices, with Circulate providing the foundational technology and scientific backing.

Keywords: Therapeutic Plasma Exchange, TPE, anti-aging, longevity, apheresis, FDA cleared, medical clinics, wellness, plasma exchange, lifespan